Adma Biologics (ADMA) Gross Margin (2011 - 2026)
Adma Biologics' Gross Margin came in at 70.81% for Q3 2026, up 14.47 percentage points from 56.34% a year earlier and up 1.45 percentage points from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Gross Margin (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Adma Biologics reported Gross Margin of 68.53%, up 13.82 percentage points year-over-year; for FY2025, it came in at 57.39%, up 5.90 percentage points from FY2024.
- Gross Margin has increased in each of the last five years, with a five-year change of +102.56 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 51.48% in FY2024 (+17.04 pp), 34.44% in FY2023 (+11.56 pp), 22.89% in FY2022 (+21.44 pp) and 1.45% in FY2021 (+46.62 pp).
- The Q3 2026 figure represents the highest quarterly Gross Margin since Q4 2011.
- Year-over-year, Gross Margin has increased for 23 consecutive quarters, with an average year-over-year change of +10.16 percentage points over the last eight quarters.
- The year-over-year gain in Gross Margin has ranged between 1.51 percentage points (Q2 2025) and 50.25 percentage points (Q4 2021) over the last five years.
- Business Quant data shows ADMA's Gross Margin at 69.36% (Q2 2026), 70.53% (Q1 2026) and 63.82% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 75.71% |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 70.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 70.81% |
| Jun 30, 2026 | 69.36% |
| Mar 31, 2026 | 70.53% |
| Dec 31, 2025 | 63.82% |
| Sep 30, 2025 | 56.34% |
| Jun 30, 2025 | 55.11% |
| Mar 31, 2025 | 53.22% |
| Dec 31, 2024 | 53.88% |
| Sep 30, 2024 | 49.78% |
| Jun 30, 2024 | 53.60% |
| Mar 31, 2024 | 47.77% |
| Dec 31, 2023 | 42.06% |
| Sep 30, 2023 | 36.65% |
| Jun 30, 2023 | 27.76% |
| Mar 31, 2023 | 29.01% |
| Dec 31, 2022 | 28.36% |
| Sep 30, 2022 | 23.50% |
| Jun 30, 2022 | 22.92% |
| Mar 31, 2022 | 12.58% |
| Dec 31, 2021 | 13.31% |
API Access
Adma Biologics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();